Therefore these results together suggested that JARID2 was required for TGF-ß-dependent changes of histone H3 methylation and EZH2 recruitment on the specific target genes during TGF-ß-induced EMT process of A549 and HT29 cancer cell lines. The gene discussed is JARID2; the disease is cancer.